Taiwan FDA registration 0b4f59e2b9015f18dc42b82a65af8d57
"Lorne" Anti-Lea Monoclonal
TW: "羅倫" 單株抗體抗Lea血清試劑
Taiwan·Risk Class 2·MD·Lorne Laboratories Ltd.·Registered Jan 21, 2019 – Jan 21, 2029ActiveRegistration details
- Analysis ID
- 0b4f59e2b9015f18dc42b82a65af8d57
- License Form
- Ministry of Health Medical Device Import No. 032130
- Customs Code
- DHA05603213007
Company information
- Manufacturer
- Lorne Laboratories Ltd.
- Manufacturer Country
- United Kingdom
- Authorized Representative
- GLORY BIOSCIENCE CO., LTD.
Product details
- Intended Use
- Identification of Lea blood grouping
- Product Type (Level 1)
- B Hematology and pathology devices
- Product Type (Level 2)
- B4020 Analyze specific reagents
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Jan 21, 2019
- Expiry Date
- Jan 21, 2029
About this record
Access comprehensive regulatory information for "Lorne" Anti-Lea Monoclonal in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 0b4f59e2b9015f18dc42b82a65af8d57 and manufactured by Lorne Laboratories Ltd.. The authorized representative in Taiwan is GLORY BIOSCIENCE CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices